Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
01/31/2025
01/31/2024
01/31/2023
01/31/2022
01/31/2021
Revenus
0
--
0
0
0
0
Croissance des revenus (H/H)
--
--
--
--
--
--
Coût des ventes
--
--
0
0
0
--
Bénéfice brut
--
--
0
0
0
--
Vente, Général et Administration
0
--
1
1
1
1
Recherche et développement
--
--
--
0
0
0
Frais d'exploitation
1
--
1
2
1
1
Autres revenus (charges) non opérationnels
--
--
--
--
--
--
Bénéfice avant impôts
-1
--
-1
-2
-1
-1
Charge d'impôt sur le revenu
--
--
0
--
--
--
Bénéfice net
-1
--
-1
-2
-1
-1
Croissance du bénéfice net
0%
--
-50%
100%
0%
-50%
Actions en circulation (diluées)
194.53
--
142.92
114.16
107.92
101.19
Variation des actions (H-H)
28.99%
--
25%
6%
7%
3%
EPS (dilué)
0
--
-0.01
-0.01
-0.01
-0.01
Croissance du EPS
-9%
--
-23%
4%
-9%
-18%
Flux de trésorerie libre
0
0
-1
0
-1
-1
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
--
--
0%
0%
0%
--
Marge opérationnelle
0%
--
0%
0%
0%
0%
Marge bénéficiaire
0%
--
0%
0%
0%
0%
Marge du flux de trésorerie libre
0%
--
0%
0%
0%
0%
EBITDA
-1
--
-1
-2
-1
-1
Marge EBITDA
0%
--
0%
0%
0%
0%
D&A pour le résultat opérationnel
0
0
0
0
0
0
EBIT
-1
--
-1
-2
-1
-1
Marge EBIT
0%
--
0%
0%
0%
0%
Taux d'imposition effectif
--
--
0%
--
--
--
Follow-Up Questions
Quels sont les états financiers clés de Predictmedix AI Inc. ?
Quels sont les ratios financiers clés pour PMEDF ?
Comment les revenus de Predictmedix AI Inc. sont-ils répartis par segment ou géographie ?
Predictmedix AI Inc. est-elle rentable ?
Predictmedix AI Inc. a-t-elle des passifs ?
Combien d'actions en circulation Predictmedix AI Inc. a-t-elle ?
Statistiques clés
Clôture préc.
$0.0426
Prix d'ouverture
$0.0442
Plage de la journée
$0.0442 - $0.0444
Plage de 52 semaines
$0.005 - $0.067
Volume
10.0K
Volume moyen
31.9K
BPA (TTM)
-0.02
Rendement en dividend
--
Capitalisation boursière
$9.1M
Qu’est-ce que PREDICTMEDIX AI INC. ?
Predictmedix AI, Inc. is a life sciences technology company, which engages in developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-12-20. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. The company has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. The company is also developing AI-powered products that address the detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. The company is adding additional modules to this Mobile Wellbeing platform that help to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.